Hospital Ruber Internacional
The cost of medication treatment for multiple sclerosis in Spain typically ranges from $3,000 to $6,000. Pricing varies depending on the specific drug (injectable, oral, or infusion therapies), the clinic or hospital, and whether additional services like neurologist consultations or MRI monitoring are included. In the United States, the average cost is $18,500 (per National MS Society). This means MS medication treatments in Spain are about 76% less than in the U.S.
Spanish clinics usually include the neurologist’s evaluation, prescription, drug administration (if infusion), and routine follow-up visits in the price. In the U.S., medication costs often cover only the drug, with separate bills for doctor consultations, MRI scans, and lab work. Always confirm which services and medications are included with your chosen clinic.
Why do patients choose Spain for medication treatment for multiple sclerosis?
Access advanced Medication treatment for multiple sclerosis solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Medication treatment for multiple sclerosis | from $2,500 | from $2,000 | from $3,000 |
| Ocrevus (ocrelizumab) | from $10,000 | from $35,000 | from $25,000 |
Day 1
Day 2
Day 3
Day 4 to Day 14
Week 3
Week 4
Week 5
Note: Each patient"s journey with multiple sclerosis differs. This plan is a general guideline and may be adjusted based on individual needs.
Principal investigator in 100+ clinical trials for multiple sclerosis – Dr. Arroyo leads groundbreaking research at Quironsalud Madrid.
Dr Romero Imbroda is a Fellow of the European Board of Neurology and President of the Andalusian Society of Neurology, specializing in multiple sclerosis treatment.
Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.
Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.